by Bonnell Foundation | Jul 6, 2015 | News
Via CNBC The U.S. Food and Drug Administration said Thursday it had approved the use of Vertex Pharmaceuticals’ Orkambi, a drug aimed to treat patients with cystic fibrosis, on patients who are at least 12 years old. The company’s shares were temporarily...
by Bonnell Foundation | Aug 1, 2012 | Featured, News
Some health concerns if your child is taking Kalydeco. Read more. Click here: http://www.fda.gov/Drugs/DrugSafety/ucm316693.htm Please check back or email us with any questions. info@roadmaptocf.org
by Bonnell Foundation | Jul 30, 2012 | News
UMHS one of six Michigan facilities linked to New Hampshire hepatitis C investigation The Michigan Department of Community Health has been investigating the employment history of a Hepatitis C-positive health care worker who was recently arrested in New Hampshire for...
by Bonnell Foundation | Jul 26, 2012 | News
Check out all the stories about fabulous people staying healthy with cystic fibrosis. http://www.everydayhealth.com/mens-health/outrunning-cystic-fibrosis.aspx
by Bonnell Foundation | May 30, 2012 | Featured, News
Affordable Care Act supports families of children with special health care needs Health and Human Services (HHS) Secretary Kathleen Sebelius today announced $4.9 million in Affordable Care Act funding to support Family-to-Family Health Information Centers, primarily...
by Bonnell Foundation | May 8, 2012 | Featured, News
Parents who have kids with the deltaF508 strain of cystic fibrosis will soon be able to breathe a little easier. Results from the clinical trials by Vertex Pharmaceutical’s have stocks climbing. The drug company climbed 55 percent to $58.12 at the close of the New...
